Neil Mcclements Email & Phone Number

London, United Kingdom

Genetic haemochromatosis is the UK’s most common genetic condition, directly affecting over 380,000 people. Although commonplace, the condition is significantly under-diagnosed in the UK - just 14,000 people are known to the NHS. Left undiagnosed & untreated, the condition can cause liver disease, cancer, heart disease, chronic fatigue, diabetes, severe joint pain, sexual health issues and neurological issues. Treatment is simple, clinically effective and cost-effective. Early diagnosis saves lives. Help us, to help others. Get in touch : ceo@huk.org.uk or office@huk.org.uk

Fintech Ventures started as a side project for angel investing whilst building Fintech Consultants and rapidly became a successful seed/early stage investment vehicle, focussed on European & US technology startups. We invest in great people, with great products/ideas targeted at high-growth markets. We're particularly focussed on tech-related businesses where we are able to contribute practical expertise, not simply funding.With over 30 investments to date, the portfolio includes :Zencoder (ex Y-Combinator) - video SAAS platform - sold to Brightcove 2012 (>$3.5m raised)Springboard Accelerator - range of successful exits 2x to 24x Amplience - rich media merchandising - thriving post series A (>$20m raised)Hectare - agritech marketplace - seedWeSwap - FX prepaid cards - seedCupris - medtech - world's first iPhone compatible otoscope - seedJupiter Diagnostics - medtech - seedTransformative - medtech (machine learning) - seed